At the time of analysis (July 2021), this database included over 3000 (n=3152) individuals diagnosed with OI, of whom 2169 carry glycine substitutions, splice site sequence variants, deletions and insertions in COL1A1 and 983 in COL1A2. This evidence concerns the gene COL1A2 and osteogenesis imperfecta.